At Alder Therapeutics, we are on a bold mission to cure the incurable by bringing pluripotent stem cell-developed therapies to the benefit of patients.
We are developing two promising allogeneic stem cell therapies, both with pre-clinical proof of concept data. Our lead program is a retinal cell therapy to treat Retinitis Pigmentosa, with a second program to tackle heart failure.
Our industry-renowned team has decades of expertise in the scientific, technical and commercial aspects of bringing game-changing allogeneic cell therapies to market. Our focus is on de-risking cell therapy development by keeping the commercial product in mind from the start.
Company Details
- Employees
- 4
- Founded
- 2022
- Address
- Nanna Svartz Väg 4, Solna,stockholm County 171 65,sweden
- Industry
- Biotechnology
- Website
- http://www.aldertx.com
- Keywords
- Plurify.
- HQ
- Solna, Stockholm County
Alder Therapeutics Questions
Alder Therapeutics's website is http://www.aldertx.com
Alder Therapeutics's LinkedIn profile is https://se.linkedin.com/company/alder-therapeutics
Alder Therapeutics has
4 employees.
View email and phone details for 4
employees at Alder Therapeutics.
Alder Therapeutics's industry is
Biotechnology
Alder Therapeutics's top competitors are
Paindrainer Ab,
Smartcella Holding Ab,
Nordic Life Science Days,
Hoya,
Biolamina,
Mycural Therapeutics,
Plurify,
Dutch Life Sciences Conference,
Brainlink Health,
Northx Biologics.
Alder Therapeutics's categories are Biotechnology
Alder Therapeutics's founding year is 2022
